相关实验视频

Updated: Sep 17, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Published on: May 3, 2024

在NLRP3通过Pyroptosis和Mitophagy调解口肌肉缩

Q Li¹, A Gao¹, C Wu¹

¹College & Hospital of Stomatology, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei, China.

Journal of dental research

|June 30, 2025

概括

诺德样受体蛋白3 (NLRP3) 炎症酶驱动着肌缩,导致细胞死亡和线粒体损伤. 抑制NLRP3可以防止肌肉损失和功能障碍.

科学领域:

生物医学科学生物医学科学
分子生物学分子生物学
肌肉生理学肌肉生理学

背景情况:

肌缩会影响闭塞功能,面部美学和生活质量.
肌缩的分子基础尚未得到充分理解.
状受体蛋白3 (NLRP3) 炎症酶与各种肌肉病有关,但其在肌缩中的作用尚不清楚.

研究的目的:

研究NLRP3炎症酶激活在肌缩中的作用和机制.
在肌肉缩模型中探索NLRP3炎症酶对肌细胞灭,线粒体功能和线粒体衰变的影响.

主要方法:

在活体大鼠模型中使用过度的正牙引力来诱导肌缩.
在肌管上进行了体外实验,以评估NLRP3炎症酶激活效应.
采用分子和细胞测试来评估热,线粒体完整性和线粒体.

主要成果:

在老鼠中,过度的正牙引力诱导了与NLRP3炎症酶激活和肌细胞烧灭增加的肌肌缩.
衰弱的肌肉显示线粒体数量减少,线粒体功能过度活化,线粒体功能受损.
抑制NLRP3抑制了热,缓解了肌肉缩,改善了线粒体功能障碍,并减少了过度的线粒细胞衰变.
实验室研究证实,NLRP3的淘汰减轻了热,缩,线粒体损伤和活性氧物种的产生.

结论:

NLRP3炎症酶激活是肌缩的关键驱动因素.
NLRP3诱导热,线粒体功能障碍和线粒体,导致肌肉质量丧失.
准NLRP3炎症酶组为食肌肉缩提供了一个潜在的治疗策略.

关键词:

作为NLR家族的一员.缩性缩 (英语:Atrophy atrophy) 是一种损伤.炎症酶体 (inflammasomes) 是一种炎症酶体.线粒体疾病是线粒体疾病.肌肉细胞肌肉细胞肌肉细胞肌肉肌肉肌肉肌肉矯正牙科矯正牙科是指矯正牙科的專業.皮林域含有3种蛋白质的3种蛋白质.

更多相关视频

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

相关概念视频

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...